Journal of Clinical Case Reports

Paradoxical Increased Risk of Thrombosis after Initiation of Vitamin K Antagonists in Thromboembolic Disease

Abstract

Rehman HU

Vitamin k Antagosnist Oral Anticoagulants (VKA) are effective in the primary and secondary prevention of venous thromboembolism, in the prevention of systemic embolism and stroke in patients with prosthetic heart valves or atrial fibrillation. In patients with thromboembolic disease Low Molecular Weight Heparin (LMWH) and oral VKA are started at diagnosis.